Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
Funding available for innovative cancer research education courses to enhance training of biomedical workforce. Focus on skills development and addressing cancer causes, diagnosis, prevention, treatment, and care.
Funder: National Institutes of Health
Due Dates: May 7, 2025 (AIDS) | May 25, 2025 | September 7, 2025 (AIDS) | September 25, 2025 | January 7, 2026 (AIDS) | January 25, 2026 | May 7, 2026 (AIDS) | May 25, 2026 | September 7, 2026 (AIDS) | September 25, 2026 | January 7, 2027 (AIDS) | January 25, 2027
Funding Amounts: Up to $300,000 direct costs per year, for up to 5 years; personnel/consultant costs capped at $150,000/year.
Summary: Supports innovative, cancer-focused educational courses to enhance skills development for the biomedical, behavioral, and clinical research workforce.
Key Information: Clinical trials are not allowed; all instructional activities must be completed within 12 months; course must be offered annually during the award.
Description
This opportunity supports the development and delivery of innovative, state-of-the-art educational courses focused on skills development in cancer research. The program aims to enhance the training of the biomedical, behavioral, and clinical research workforce by funding courses that address the causes, diagnosis, prevention, or treatment of cancer, as well as rehabilitation and continuing care for cancer patients and their families. Courses may be delivered in-person, online, or in a hybrid format, and must be completed within a 12-month period each year of funding.
The program is intended to complement, not duplicate, existing federally funded research training and education programs. It is not a substitute for institutional training grants (e.g., T32) and does not support full-time, year-long participants.
